GSK exec discusses FDA’s different take on multiple myeloma drug

GSK submitted the same Blenrep clinical trial data to global regulators and the FDA, but received a slightly more limited regulatory approval in the U.S. In an interview during the annual meeting of the American Society of Hematology, GSK oncology executive Hesham Abdullah explained what else the FDA wants from Blenrep clinical trials.

Editor's Pick

Top Story At ASH, GSK's Top Cancer Exec Discusses the FDA's Different Take on Multiple Myeloma Drug Blenrep GSK submitted the same Blenrep clinical trial data to global regulators and the FDA, but received a slightly more limited regulatory approval in the U.S. In an interview during the annual meeting of the American Society of Hematology, GSK oncology executive Hesham Abdullah explained what else the FDA wants from Blenrep clinical trials. Sponsored How to Choose the Right Dental Supply Company for Your Practice Presented by ProDentUSA With the right dental supplier, you can ensure your practice's efficiency and profitability. Learn what to consider and how a modern, direct-to-practitioner model can benefit you. Learn More

Featured News

Moving Beyond an Insurance-Based Framework for Healthcare [Sponsored] In an interview, UberDoc CEO Sean Kearney described how it is carving a niche for healthcare that better serves patients and physicians. Theranostics Could Transform Cancer Care, GE Healthcare Leader Says Theranostics — which combines molecular imaging with targeted therapy — is quickly becoming a significant innovation in cancer care, offering more precise treatment with fewer side effects. GE Healthcare expects the field to grow rapidly over the next decade, as long as hospitals can continue to invest in the imaging and software infrastructure needed to scale these therapies. Angle Health Secures $134M to Grow Benefits Platform for Small Businesses Angle Health's Series B round was led by Portage and included participation from Blumberg Capital, Mighty Capital, PruVen Capital, SixThirty Ventures, TSVC, Wing VC and Y Combinator. Why Strengthening the Dental Hygienist Profession is Key to Solving Our Oral Health Crisis Reinforcing educational standards will enable hygienists to perform more advanced procedures and raise the standard of care. How Care Transitions Complicate Medication Management — and How to Fix Them Every clinical encounter must be viewed as a medication reconciliation opportunity and primary care physicians are the coordinators-in-chief.

Video   What Are Investors Looking For In Mental Health Startups? At a recent behavioral health tech conference, Emily Durfee, a partner at Healthworx Ventures, shared her thoughts on how to differentiate mental health startups in an increasingly crowded market. She said it's important to figure out if the startup is solving a key problem for their customer — whether that's a provider, payer, employer or consumer.

Sponsored As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities Presented by Munich Re Specialty – North America In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play. Learn More

Resources

MedCity FemFwd: How Women's Health Advocates Is Pushing for Change In this episode, we're joined by Liz Powell, founder of Women's Health Advocates. We discussed the organization's policy priorities in the women's health space. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe